About SynaHealth

About SynaHealth

Welcome to SynaHealth, where we blend the art of science with the spirit of innovation to help you unlock your true potential. We're not just a brand; we're a dedicated community that believes in the endless possibilities of the human body and mind. Our mission is to elevate your physical and mental performance, nurture your overall well-being, and redefine the boundaries of personal achievement.

Our Vision

At SynaHealth, we have a profound vision that fuels our every endeavor: to inspire individuals to transcend their limits, break new ground, and attain their personal zenith. We firmly believe that with the right tools, guidance, and mindset, you can transform your life, improve your performance, and thrive in every facet of your journey.

Meet the Founder: Dr. Adnan Mjalli

Dr. Adnan Mjalli, the luminary who ignited the spark for SynaHealth, is a distinguished scientist, entrepreneur, and humanitarian. His remarkable journey spans the fields of pharmaceuticals and biochemistry, yet his true passion lies in unlocking the boundless potential of the human spirit.

Dr. Mjalli is an internationally recognized entrepreneur in the business of drug discovery and development of new medicines in the pharmaceutical and biotechnology industry. Dr. Mjalli is the founder of TransTech Pharma, LLC and High Point Pharmaceuticals, both of which are drug discovery, development and commercialization companies now under vTv Therapeutics, LLC, High Point Clinical Trials Center (HPCTC) Inc., a clinical trials research and development center that conducts human clinical trials and PharmaCore Inc., a drug manufacturing company. Dr. Mjalli served as Chairman and CEO of TransTech Pharma from December 1998-April 2014. He currently severs as CEO of High Point Clinical Trials Center and Chairman of PharmaCore.

Dr. Mjalli obtained his Ph.D. in Medicinal Chemistry in 1989 from the University of Exeter, UK. His postdoctoral work was carried out at the University of Rochester. Dr. Mjalli has held various positions of increasing responsibility in research and senior management at several pharmaceutical and biotechnology companies including Merck & Co., Inc. and Ontogen Corporation. He is the author of more than 40 scientific papers, four book chapters and an inventor on more than 700 patents and patent applications.

With a profound understanding of the intricate tapestry of human physiology and a relentless pursuit of excellence, Dr. Mjalli has been at the forefront of pioneering scientific research and innovative product development. His work not only transcends the boundaries of traditional medicine but also opens doors to groundbreaking solutions that empower individuals to overcome challenges, recover more swiftly, and flourish in their pursuits.

SynaHealth represents more than just a brand; it embodies a legacy of exploration and discovery, guided by Dr. Mjalli's unwavering commitment to pushing the boundaries of human potential. Together, we embark on a journey to help you transform aspirations into tangible accomplishments. Join us in the pursuit of redefining your limits, embracing your full potential, and experiencing life's boundless possibilities. Welcome to the SynaHealthfamily, where we're not just dreaming of the future – we're shaping it.